Bentley Pharmaceuticals to Host Second Quarter Results Conference Call and Webcast on Wednesday, July 28, 2004

London Stock Exchange
Advanced charts
Premium community
Data download

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Basepoint	LSE:BNT	London	Ordinary Share	GB0007381295	ORD 10P

Share Name

Share Symbol

Market

Type

Share ISIN

Share Description

Basepoint

LSE:BNT

London

Ordinary Share

GB0007381295

ORD 10P

Price Change

% Change

Share Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

14.75

0.00

00:00:00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Industry Sector

Turnover

Profit

EPS - Basic

PE Ratio

Market Cap

N/A

Bentley Pharmaceuticals to Host Second Quarter Results Conference Call and Webcast on Wednesday, July 28, 2004

21/07/2004 1:00pm

PR Newswire (US)

Basepoint (LSE:BNT)
Historical Stock Chart

From Nov 2019 to Nov 2024

Bentley Pharmaceuticals to Host Second Quarter Results Conference Call and Webcast on Wednesday, July 28, 2004 EXETER, N.H., July 21 /PRNewswire-FirstCall/ -- Bentley Pharmaceuticals, Inc. (NYSE:BNT), a technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe, today announced that it will release its 2004 second quarter results for the three and six months ended June 30, 2004 before the open of the market on Wednesday, July 28, 2004. Management will host a conference call to discuss these results at 10:00 a.m. Eastern Daylight Savings Time on that day. To participate on the call within the U.S. and Canada, please dial (800) 399-3081 approximately 10 minutes prior to the scheduled start time and give the password "BENTLEY." International participants may dial (706) 679-0718; the password is the same. The conference will also be broadcast live on the Internet and may be accessed via the Company's web site, http://www.bentleypharm.com/. A replay of the conference call will be available through August 4, 2004. Listeners may access the replay via the Company's website, http://www.bentleypharm.com/, or by dialing (800) 642-1687 from within the U.S. and Canada and using access code 8816411. A replay of the conference call from international locations may be accessed by dialing (706) 645-9291 using the same access code. Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and pharmaceutical products. Bentley's proprietary drug technologies enhance or facilitate the absorption of pharmaceutical compounds across various membranes. Bentley also manufactures and markets a growing portfolio of generic and branded pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and neurological diseases through its subsidiaries, Laboratorios Belmac, Laboratorios Davur and Laboratorios Rimafar; and manufactures and sells active pharmaceutical ingredients through its subsidiary, Bentley API. Copies of Bentley Pharmaceuticals' press releases and other information may be obtained through Bentley's web site at http://www.bentleypharm.com/. DATASOURCE: Bentley Pharmaceuticals, Inc. CONTACT: Michael D. Price, Vice President, Chief Financial Officer of Bentley Pharmaceuticals, Inc., +1-603-658-6100; or Investor Relations - Jonathan Birt, Lanie Marcus, or Sean Leous of Financial Dynamics, +1-212-850-5600, for Bentley Pharmaceuticals, Inc. Web site: http://www.bentleypharm.com/

	Real-time Prices	Level 2
London Stock Exchange
Chi-X Europe
BATS Europe
Aquis Exchange
FTSE Indices
Euronext
New York Stock Exchange
NASDAQ
American Stock Exchange
Dow Jones Indices
Forex
Precious Metal

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

BNT Basepoint